Infection and Drug Resistance (Jun 2023)

Risk Factor for Superimposed Nosocomial Bloodstream Infections in Hospitalized Patients with COVID-19

  • Sathaporn N,
  • Khwannimit B

Journal volume & issue
Vol. Volume 16
pp. 3751 – 3759

Abstract

Read online

Natthaka Sathaporn, Bodin Khwannimit Division of Critical Care Medicine, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, 90110, ThailandCorrespondence: Natthaka Sathaporn, Division of Critical Care Medicine, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, 15 Kanchanavanich Road, Hat Yai, Songkhla, 90110, Thailand, Tel +66-887907414, Fax +66-74281457, Email [email protected]: Corticosteroids are a component of the standard therapy for patients with coronavirus disease 2019 (COVID-19) because of the immunological dysregulation and hyperinflammation associated with the condition. This study aimed to evaluate the potential risk factors for nosocomial bloodstream infections in hospitalized patients with COVID-19, including the exploration of corticosteroid dosage and treatment duration.Materials and Methods: A retrospective cohort study of hospitalized patients with COVID-19 was conducted in a tertiary care hospital. We performed univariate and multivariate analyses of various parameters to identify risk factors for nosocomial bloodstream infection.Results: Of 252 patients, 19% had nosocomial bloodstream infections. The mortality rate of nosocomial bloodstream infections was 62.5%. Multivariate analysis revealed that male sex (odds ratio [OR] 3.43; 95% confidence interval [CI]: 1.60– 7.33), receiving methylprednisolone (OR: 3.01; 95% CI: 1.24– 7.31), receiving an equivalent dexamethasone dose of 6– 12 mg/day (OR: 7.49; 95% CI: 2.08– 26.94), and leukocytosis on admission (OR: 4.13; 95% CI: 1.89-9.01) were significant predictors of nosocomial bloodstream infections.Conclusion: Unmodified risk variables for nosocomial bloodstream infections included male sex and leukocytosis at admission. Using methylprednisolone and obtaining a cumulative dosage of dexamethasone were adjusted risk variables associated with superimposed nosocomial bloodstream infections in hospitalized patients with COVID-19.Keywords: bloodstream infection, risk factor, COVID-19, methylprednisolone, corticosteroid

Keywords